Get notified when TWAV files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsrevenue $707,000, net income $1.7M. TaoWeave pivots to Bittensor staking, ends Mezzanine product line, strips MD&A detail
Filed May 15, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 13, 2025 · ~2 min read
Key Changes
-
high
Risk Factors: Mezzanine end-of-life verify on EDGAR →
-
high
Company now stakes substantially all TAO tokens through third-party custodians and validators, relies on selling TAO to fund operations, but has no committed credit facilities and faces liquidity risk from volatile TAO prices and limited exchange liquidity.
Risk Factors: TAO liquidity and conversion verify on EDGAR → -
high
MD&A section stripped of all quarterly financial results, segment performance tables, and operating expense breakdowns; replaced with brief boilerplate on accounting estimates, eliminating operational transparency.
MD&A: segment results removed verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (SPWH 10-Q) is open in full — no account needed.
Partner
Trade TWAV commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 4, 2026 · How we verify